POSTMARKETING SURVEILLANCE OF THE SAFETY OF CIMETIDINE - MORTALITY DURING 2ND, 3RD, AND 4TH YEARS OF FOLLOW UP

被引：44

作者：

COLINJONES, DG

LANGMAN, MJS

LAWSON, DH

VESSEY, MP

机构：

[1] RADCLIFFE INFIRM, DEPT COMMUNITY MED & GEN PRACTICE, GIBSON LABS BLDG, OXFORD OX2 6HE, ENGLAND

[2] GLASGOW ROYAL INFIRM, DEPT CLIN PHARMACOL, GLASGOW G4 0SF, SCOTLAND

[3] UNIV NOTTINGHAM HOSP, DEPT THERAPEUT, NOTTINGHAM NG7 2UH, ENGLAND

[4] QUEEN ALEXANDRA HOSP, PORTSMOUTH, HANTS, ENGLAND

来源：

BMJ-BRITISH MEDICAL JOURNAL | 1985年 / 291卷 / 6502期

关键词：

D O I：

10.1136/bmj.291.6502.1084

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1084 / 1088

页数：5

共 5 条

[1] BURGESS E, 1982, RENAL PHYSIOL BIOCH, V5, P27
[2] POSTMARKETING SURVEILLANCE OF THE SAFETY OF CIMETIDINE - 12 MONTH MORTALITY REPORT
COLINJONES, DG
LANGMAN, MJS
LAWSON, DH
VESSEY, MP
[J]. BMJ-BRITISH MEDICAL JOURNAL, 1983, 286 (6379): : 1713 - 1716
[3] CIMETIDINE AND GASTRIC-CANCER - PRELIMINARY-REPORT FROM POST-MARKETING SURVEILLANCE STUDY
COLINJONES, DG
LANGMAN, MJS
LAWSON, DH
VESSEY, MP
[J]. BRITISH MEDICAL JOURNAL, 1982, 285 (6351) : 1311 - 1313
[4] JONES DGC, 1985, Q J MED, V54, P253
[5] PROSPECTIVE-STUDY OF EARLY GASTRIC-CANCER
TSUKUMA, H
MISHIMA, T
OSHIMA, A
[J]. INTERNATIONAL JOURNAL OF CANCER, 1983, 31 (04) : 421 - 426